查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1997450

动物肠道健康市场：2026-2032年全球市场预测（依产品类型、目标动物、剂型、应用及通路划分）

Animal Intestinal Health Market by Product Type, Animal Type, Formulation, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，动物肠道健康市场价值将达到 45.2 亿美元，到 2026 年将成长至 47.9 亿美元，到 2032 年将达到 68.8 亿美元，年复合成长率为 6.17%。

主要市场统计数据
基准年 2025 45.2亿美元
预计年份：2026年 47.9亿美元
预测年份 2032 68.8亿美元
复合年增长率 (%) 6.17%

在微生物组科学的指导下，将肠道健康作为整个动物生产系统中商业性和永续性的核心驱动力进行策略性实施。

动物肠道健康领域已从一种小众的营养补充品发展成为畜牧业、水产养殖业和伴侣动物生产系统的核心支柱。微生物组科学的进步重新定义了肠道健康，将其视为一种受饲料配方、靶向生物活性物质、宿主免疫力和管理措施等多因素影响的结果。因此，生产者和价值链上的相关人员越来越重视制定以优化肠道功能为核心的干预策略，以提高动物的适应能力、资源利用效率和福祉。

科学突破、监管压力和数位物流的整合如何加速动物肠道健康领域的一体化产品创新和应用。

过去五年，肠道健康领域经历了翻天覆地的变化，产品系列、供应链和消费者期望都发生了重塑。科学的进步拓展了有效干预方案的范围，从单一模式疗法发展到整合酶、有机酸、植物萃取物、益生元和益生菌等多种成分，并结合性能诊断技术。菌株鑑定技术的进步、提高稳定性的包封技术以及针对不同物种和生命阶段特定生理需求的颗粒製剂的开发，都在加速这一整合进程。

评估 2025 年关税对动物肠道健康生态係原料采购、配方决策和供应链韧性的影响。

2025年新关税措施的实施，凸显了依赖跨国原料分销和配方产品的相关人员面临的贸易和成本复杂性。这些关税正在影响进口酵素复合物、特殊有机酸和专有益生菌菌株的经济效益，迫使製造商和经销商重新评估其筹资策略和库存政策。在实践中，采购部门越来越重视供应商多元化、本地製造伙伴关係以及后向整合，以在控製成本的同时维持供应的连续性。

以细分市场为中心的洞察，揭示产品类型、动物物种生理、预期用途、配方限制和分销策略如何决定开发路径。

深入的市场区隔分析揭示了不同产品类型、动物种类、应用领域、配方和分销管道的市场需求驱动因素和产品开发重点。依产品类型划分，市场可细分为酵素、有机酸、植物来源成分、益生元和益生菌。酵素又可细分为植酸酶、蛋白酶和木聚醣酶，而益生菌则可细分为细菌益生菌和酵母益生菌。这种细分凸显了配方科学的重要性，即需要使触媒活性、pH耐受性和微生物相容性与目标饲料基质相匹配。依动物种类划分，市场可细分为水产养殖、伴侣动物、家禽、反刍动物和猪。水产养殖进一步细分为鱼类和虾类，伴侣动物细分为猫和狗，家禽细分为肉鸡、蛋鸡和火鸡，反刍动物细分为牛、牛和山羊，猪细分为种猪、育肥猪和母猪及仔猪。这些分类突显了不同物种和生命週期中肠道生理功能的差异，而这些差异决定了不同的给药策略、载体系统和疗效证据标准。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势和战略意义，这些趋势和意义驱动着采购、监管策略和商业化。

区域差异是影响供应策略、监管合规性和农场实施的关键因素，美洲、欧洲、中东和非洲以及亚太地区的独特趋势塑造了商业性机会和风险。在美洲，大规模商业家禽和生猪养殖场优先考虑饲料转换率和合理使用抗生素，这推动了市场需求，促使酵素製剂和益生菌干预措施与精准饲餵平台相结合得到快速应用。在欧洲、中东和非洲，法规结构和消费者期望强调减少抗生素使用和可追溯性，推动了对可严格检验且易于记录的解决方案的需求，并促进了原材料开发商和当地配料商之间的合作。

公司的竞争策略以独特的科学、可扩展的製造和一体化的服务模式为中心，以确保与竞争对手的差异化和获利能力。

竞争趋势日益取决于能否将科学可靠性与可扩展的生产能力和法规遵从性结合。主要企业正投资于菌株表征、专利酶技术和多位点稳定性测试，以确保其产品功效不受物种或配方限制。除了产品创新之外，成功的企业还透过投资供应链来提升自身竞争力，例如在地化生产、契约製造伙伴关係以及生物活性材料的强化低温运输物流。这些能力缩短了产品上市时间，并使其在商品化带来的价格压力下获得竞争优势。

领导者可采取的策略重点是将科学创新转化为具有韧性的供应链、检验的配方和在地化优化的商业模式。

产业领导者应优先考虑一系列切实可行的倡议，将科学潜力转化为商业性成功。首先，研发蓝图应与物种特异性证据的创建一致，这些证据应着重于农场层面的最终目标，例如饲料转换率、发病率降低以及在环境条件波动下的耐受性。其次，投资配方和输送技术，以保护生物活性成分在加工和储存过程中不受损害，从而扩大分销范围并减少产品损失。第三，透过双重采购、在地化生产和策略性库存布局来增强供应链韧性，进而降低关税和物流中断带来的风险。

一种结合一手访谈、文献整合、农场检验和基于情境的供应链压力测试的调查方法，以获得实用见解。

本调查方法整合了访谈、文献综述和跨领域检验研讨会，以确保研究结果的稳健性、可重复性和对商业性决策的实用性。一手资料包括对饲料生产商、原料供应商和大型生产商的研发经理、采购专家和销售经理进行的结构化访谈，并辅以农场案例研究，检验产品在生产环境中的表现。二手资料则来自同行评审期刊、监管出版刊物和行业会议论文集，使分析与最新的科学共识和政策趋势保持一致。

摘要将肠道健康定位为系统层面的策略重点，需要证据、韧性和在地化的商业化。

总之，肠道健康正日益成为一个策略性领域，科学、监管、供应链和商业性执行在此交汇融合。微生物组研究的进展、监管政策逐渐减少对抗生素的使用，以及更强大的製剂和递送技术的出现，都为生产商和製剂研发人员提供了更多选择。同时，2025年的贸易和关税趋势凸显了供应链弹性和区域製造能力的重要性。为了在这种环境下取得成功，企业必须整合严谨的证据产生、灵活的筹资策略以及针对特定区域的市场进入模式。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：动物肠道健康市场：依产品类型划分

  • 酵素
    • 植酸酶
    • 蛋白酶
    • 木聚醣酶
  • 有机酸
  • 植物源
  • 益生元
  • 益生菌
    • 细菌益生菌
    • 酵母来源的益生菌

第九章：动物肠道健康市场：依动物类型划分

  • 水产养殖
    • 鱼
    • 虾
  • 伴侣动物
    • 猫
    • 狗
  • 家禽
    • 肉鸡
    • 产蛋母鸡
    • 土耳其
  • 反刍动物
    • 牛
    • 牛
    • 绵羊和山羊
  • 猪
    • 用于繁殖
    • 肥育猪
    • 母猪和小猪

第十章：以剂型分類的动物肠道保健市场

  • 液体
  • 颗粒
  • 粉末

第十一章 动物肠道健康市场：依应用领域划分

  • 饲料添加剂
  • 营养补充品
  • 治疗

第十二章：动物肠道健康市场：依分销管道划分

  • 离线
    • 直销
    • 销售代理
  • 在线的

第十三章：动物肠道健康市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：动物肠道健康市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：动物肠道健康市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国动物肠道健康市场

第十七章：中国动物肠道健康市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AB Vista
  • AdvaCare Pharma
  • Archer Daniels Midland Company
  • BASF SE
  • Bluestar Adisseo Co., Ltd.
  • Cargill, Incorporated
  • Evonik Industries AG
  • International Flavors & Fragrances Inc.
  • Kemin Industries, Inc.
  • Kerry Group plc
  • Koninklijke DSM NV
  • Novonesis A/S
  • Zoetis Inc.
Product Code: MRR-501246438090

The Animal Intestinal Health Market was valued at USD 4.52 billion in 2025 and is projected to grow to USD 4.79 billion in 2026, with a CAGR of 6.17%, reaching USD 6.88 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.52 billion
Estimated Year [2026] USD 4.79 billion
Forecast Year [2032] USD 6.88 billion
CAGR (%) 6.17%

A strategic introduction that situates intestinal health as a core commercial and sustainability lever across animal production systems guided by microbiome science

The landscape of animal intestinal health has evolved from niche nutritional supplements to a central pillar of livestock, aquaculture, and companion animal production systems. Advances in microbiome science have reframed intestinal health as a multifactorial outcome driven by feed formulation, targeted bioactives, host immunity, and management practices. As a result, producers and value chain stakeholders are increasingly orienting strategy around interventions that optimize gut function to improve resilience, resource efficiency, and animal welfare.

Concurrently, regulatory momentum away from medically important antibiotics and toward evidence-based alternatives has elevated demand for precision feed additives and targeted nutritional strategies. This shift is accompanied by technological integration in product delivery, diagnostic monitoring, and data-driven decision-making. Collectively, these developments mean that intestinal health is no longer an isolated technical consideration but a strategic lever for profitability, sustainability, and market differentiation across species and production systems.

How converging scientific breakthroughs, regulatory pressure, and digital logistics are accelerating integrated product innovation and adoption across animal intestinal health

The past five years have witnessed transformative shifts that are reshaping product portfolios, supply chains, and buyer expectations in the intestinal health arena. Scientific advancements have broadened the palette of efficacious interventions beyond single-mode solutions to integrated regimens that combine enzymes, organic acids, phytogenics, prebiotics, and probiotics with performance diagnostics. This integration has been accelerated by improvements in strain characterization, encapsulation technologies that enhance stability, and granular formulations that match species- and life-stage-specific physiological needs.

In addition, regulatory and market pressures have incentivized the replacement of broad-spectrum antimicrobial growth promotants with evidence-based alternatives, catalyzing investment in clinical trials, biomarker development, and on-farm validation studies. Parallel to product innovation, digital and logistics innovations are enabling more precise dosing, traceability, and rapid-response supply adjustments, thereby reducing the time between scientific discovery and commercial adoption. Taken together, these shifts are creating a more complex but opportunity-rich landscape in which cross-functional collaboration between R&D, regulatory, and commercial teams becomes a competitive necessity.

Assessment of 2025 tariff impacts on ingredient sourcing, formulation decisions, and supply chain resilience within the animal intestinal health ecosystem

The introduction of new tariff measures in 2025 has introduced a tangible layer of trade and cost complexity for stakeholders who depend on cross-border ingredient flows and formulated products. Tariffs affect the economics of imported enzymatic complexes, specialty organic acids, and proprietary probiotic strains, prompting manufacturers and distributors to reassess sourcing strategies and inventory policies. In practice, this means procurement teams are increasingly evaluating supplier diversification, local manufacturing partnerships, and backward integration to maintain supply continuity while managing landed costs.

Moreover, tariff-induced price signals are reinforcing demand for domestically producible inputs and regionally tailored formulations. As a result, some value chain players are accelerating formulation simplification where feasible, while others are investing in ingredient substitution studies and stability testing to validate locally available alternatives. These dynamics have downstream implications for product differentiation, with premium solutions that demonstrate verifiable performance and cost-efficiency gaining competitive advantage. In parallel, the regulatory scrutiny accompanying tariff policy is encouraging transparency in sourcing and compliance, further increasing the administrative burden on smaller suppliers and creating consolidation pressures across the distribution channel.

Segment-focused insights revealing how product type, species physiology, application intent, formulation constraints, and distribution strategy determine development pathways

Insightful segmentation analysis reveals differentiated demand drivers and product development priorities across product type, animal type, application, formulation, and distribution channel segments. Based on Product Type, the market is studied across Enzymes, Organic Acids, Phytogenics, Prebiotics, and Probiotics, with Enzymes further studied across Phytase, Protease, and Xylanase and Probiotics further delineated into Bacterial Probiotics and Yeast Probiotics; this delineation highlights the need for formulation science that aligns catalytic activity, pH tolerance, and microbial compatibility with target feed matrices. Based on Animal Type, the market is studied across Aquaculture, Companion Animals, Poultry, Ruminants, and Swine, with Aquaculture further studied across Fish and Shrimp, Companion Animals across Cat and Dog, Poultry across Broiler, Layer, and Turkey, Ruminants across Beef Cattle, Dairy Cattle, and Sheep And Goat, and Swine across Breeder, Grower Finisher, and Sow And Piglet; these distinctions underscore species- and lifecycle-specific gut physiology that dictates different dosing strategies, carrier systems, and evidence thresholds for efficacy.

Based on Application, the market is studied across Feed Additive, Nutritional Supplement, and Therapeutic, which implies divergent regulatory pathways, claims substantiation demands, and commercial channels for adoption, while Based on Formulation, the market is studied across Liquid, Pellet, and Powder, indicating formulation constraints related to stability, heat tolerance, and on-farm handling. Finally, Based on Distribution Channel, the market is studied across Offline and Online, with Offline further studied across Direct Sales and Distributor, reflecting evolving go-to-market strategies where direct-to-producer models coexist with distributor networks and digital commerce. Collectively, these segmentation lenses reveal that product development, regulatory strategy, and commercial execution must be tightly aligned to species-specific biology, application intent, and preferred delivery format to accelerate adoption and demonstrate measurable outcomes.

Regional dynamics and strategic implications across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine sourcing, regulatory strategy, and commercialization

Regional differentiation is a decisive factor for supply strategies, regulatory compliance, and on-farm adoption, with distinct dynamics in the Americas, Europe, Middle East & Africa, and Asia-Pacific shaping commercial opportunity and risk. In the Americas, demand drivers are shaped by large-scale commercial poultry and swine operations that prioritize feed conversion and antimicrobial stewardship, prompting rapid adoption of enzyme and probiotic-based interventions that integrate with precision feeding platforms. In Europe, Middle East & Africa, regulatory frameworks and consumer expectations emphasize antibiotic reduction and traceability, which fuels demand for rigorously validated, documentation-ready solutions and encourages partnerships between ingredient innovators and local formulators.

In Asia-Pacific, intensive aquaculture and mixed-species production present both scale and complexity, driving demand for tailored enzyme blends, robust acidifiers, and locally relevant probiotic strains, while online distribution and contract manufacturing models enable rapid scaling. Across regions, the interplay between regional raw material availability, divergent regulatory regimes, and distribution infrastructure necessitates adaptive market entry strategies that balance local partnerships, regulatory intelligence, and formulation flexibility. Consequently, companies that develop region-specific evidence packages and operational models are better positioned to capture cross-border growth while mitigating trade and compliance risks.

Competitive company strategies centered on proprietary science, scalable manufacturing, and integrated service models to secure differentiation and margin

Competitive dynamics are increasingly influenced by the ability to combine scientific credibility with scalable manufacturing and regulatory competence. Key companies are investing in strain characterization, patent-protected enzyme technologies, and multi-site stability studies to substantiate product claims across species and formulations. In addition to product innovation, successful firms are differentiating through supply chain investments such as localized production, contract manufacturing partnerships, and enhanced cold-chain logistics for sensitive biologicals. These capabilities reduce time to market and provide a competitive moat against commodity pricing pressures.

Furthermore, strategic partnerships between ingredient innovators, feed formulators, and service providers are becoming more common, enabling bundled offerings that pair actives with dosers, diagnostics, and on-farm training. This ecosystem approach increases switching costs for end users and creates opportunities for value-added services that extend beyond the point of sale. For leadership teams, the takeaway is clear: scaling R&D, ensuring regulatory readiness across target markets, and embedding distribution and technical service within commercial models are essential to sustain growth and defend margin in a rapidly professionalizing market.

Actionable strategic priorities for leaders to convert scientific innovation into resilient supply chains, validated formulations, and regionally tailored commercial models

Industry leaders should prioritize a set of actionable initiatives to convert scientific promise into commercial outcomes. First, align R&D roadmaps with species-specific evidence generation that addresses on-farm endpoints such as feed efficiency, morbidity reduction, and resilience under variable environmental conditions. Second, invest in formulation and delivery technologies that protect biological actives across processing and storage environments, enabling broader distribution and lower product loss. Third, pursue supply chain resilience through dual-sourcing, regional manufacturing, and strategic inventory positioning to mitigate tariff and logistics disruption risks.

In parallel, commercial teams should develop regionally tailored value propositions that reflect local regulatory expectations and buyer purchasing patterns, including digital channels for technical education and sales conversion. Executives should also consider strategic partnerships that combine diagnostic capabilities with product bundles to demonstrate measurable outcomes and create recurring-service revenue. Finally, establish cross-functional commercialization sprints that rapidly translate trial results into label claims, marketing assets, and distributor training, thereby shortening the adoption curve and improving return on innovation investment.

Methodological framework combining primary interviews, literature synthesis, on-farm validation, and scenario-based supply chain stress testing for actionable findings

The research methodology synthesizes primary interviews, secondary literature review, and cross-functional validation workshops to ensure findings are robust, replicable, and relevant to commercial decision-making. Primary inputs include structured interviews with R&D leaders, procurement specialists, and commercial managers across feed manufacturers, ingredient suppliers, and large producers, complemented by on-farm case studies that validate product performance under production conditions. Secondary inputs are drawn from peer-reviewed journals, regulatory publications, and industry conference proceedings to ground analysis in current scientific consensus and policy trends.

Analytical approaches include comparative formulation analysis, supply chain stress testing under alternative tariff and logistics scenarios, and segmentation mapping that links product attributes to species-specific physiological requirements and application intents. Findings were triangulated through expert workshops and sensitivity checks to ensure practical relevance. Wherever possible, methodological transparency was maintained by documenting data sources, interview protocols, and assumptions used in constructing scenario analyses and strategic recommendations.

Concluding synthesis that positions intestinal health as a systems-level strategic priority requiring evidence, resilience, and regionally tailored commercialization

In conclusion, intestinal health is an increasingly strategic domain that intersects science, regulation, supply chain, and commercial execution. The convergence of microbiome research, regulatory shifts away from antibiotics, and the advent of more robust formulation and delivery technologies has expanded the toolkit available to producers and formulators. At the same time, trade dynamics and tariff developments in 2025 have underscored the importance of supply chain agility and regional manufacturing capabilities. To win in this environment, companies must integrate rigorous evidence generation with resilient sourcing strategies and region-specific go-to-market models.

Looking ahead, the organizations that will succeed are those that treat intestinal health as a systems-level challenge rather than a discrete product category. By investing in species-specific efficacy studies, formulation science, and operational resilience, stakeholders can translate technical innovations into commercial advantage while meeting evolving regulatory and consumer expectations. The recommended path forward emphasizes cross-functional collaboration, regional adaptation, and measurable outcome orientation to sustainably capture the value inherent in healthier animals and more efficient production systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Intestinal Health Market, by Product Type

  • 8.1. Enzymes
    • 8.1.1. Phytase
    • 8.1.2. Protease
    • 8.1.3. Xylanase
  • 8.2. Organic Acids
  • 8.3. Phytogenics
  • 8.4. Prebiotics
  • 8.5. Probiotics
    • 8.5.1. Bacterial Probiotics
    • 8.5.2. Yeast Probiotics

9. Animal Intestinal Health Market, by Animal Type

  • 9.1. Aquaculture
    • 9.1.1. Fish
    • 9.1.2. Shrimp
  • 9.2. Companion Animals
    • 9.2.1. Cat
    • 9.2.2. Dog
  • 9.3. Poultry
    • 9.3.1. Broiler
    • 9.3.2. Layer
    • 9.3.3. Turkey
  • 9.4. Ruminants
    • 9.4.1. Beef Cattle
    • 9.4.2. Dairy Cattle
    • 9.4.3. Sheep And Goat
  • 9.5. Swine
    • 9.5.1. Breeder
    • 9.5.2. Grower Finisher
    • 9.5.3. Sow And Piglet

10. Animal Intestinal Health Market, by Formulation

  • 10.1. Liquid
  • 10.2. Pellet
  • 10.3. Powder

11. Animal Intestinal Health Market, by Application

  • 11.1. Feed Additive
  • 11.2. Nutritional Supplement
  • 11.3. Therapeutic

12. Animal Intestinal Health Market, by Distribution Channel

  • 12.1. Offline
    • 12.1.1. Direct Sales
    • 12.1.2. Distributor
  • 12.2. Online

13. Animal Intestinal Health Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Animal Intestinal Health Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Animal Intestinal Health Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Animal Intestinal Health Market

17. China Animal Intestinal Health Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AB Vista
  • 18.6. AdvaCare Pharma
  • 18.7. Archer Daniels Midland Company
  • 18.8. BASF SE
  • 18.9. Bluestar Adisseo Co., Ltd.
  • 18.10. Cargill, Incorporated
  • 18.11. Evonik Industries AG
  • 18.12. International Flavors & Fragrances Inc.
  • 18.13. Kemin Industries, Inc.
  • 18.14. Kerry Group plc
  • 18.15. Koninklijke DSM N.V.
  • 18.16. Novonesis A/S
  • 18.17. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ANIMAL INTESTINAL HEALTH MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ANIMAL INTESTINAL HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ANIMAL INTESTINAL HEALTH MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROTEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROTEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROTEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY XYLANASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY XYLANASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY XYLANASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORGANIC ACIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORGANIC ACIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORGANIC ACIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTOGENICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTOGENICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTOGENICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PREBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BACTERIAL PROBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BACTERIAL PROBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BACTERIAL PROBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY YEAST PROBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY YEAST PROBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY YEAST PROBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FISH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FISH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FISH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHRIMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHRIMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHRIMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DOG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DOG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DOG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BROILER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BROILER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BROILER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LAYER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LAYER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LAYER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY TURKEY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY TURKEY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY TURKEY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BEEF CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BEEF CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BEEF CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DAIRY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DAIRY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHEEP AND GOAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHEEP AND GOAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHEEP AND GOAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BREEDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BREEDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BREEDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROWER FINISHER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROWER FINISHER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROWER FINISHER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SOW AND PIGLET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SOW AND PIGLET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SOW AND PIGLET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PELLET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PELLET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PELLET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FEED ADDITIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FEED ADDITIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FEED ADDITIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 242. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 257. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 258. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 260. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 261. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 263. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 264. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 265. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 266. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 267. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 268. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 270. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 299. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 300. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 302. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 303. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 305. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 306. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 307. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 308. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 309. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 310. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 311. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 312. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 313. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 314. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 316. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 317. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 319. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 320. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 321. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2032 (USD MILLION)
  • TABLE 322. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 323. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 324. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 325. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 326. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2032 (US